Sidebar Ads

Thursday, February 28, 2019

Home » , » Novartis faces shareholder criticism over drug prices at AGM

Novartis faces shareholder criticism over drug prices at AGM

By  February 28, 2019  No comments
Novartis's shift into high-tech drugs won praise for giving new options to patients but criticism for prices that may run into the millions of dollars as the Swiss drugmaker faced investors at its annual general meeting on Thursday.


from Reuters: Business News https://ift.tt/2NyiPc5

0 comments:

Post a Comment

Why some pubs are 'getting it tight' on rates and what it could mean for your pint

Hotels have overall had an 84% rates increase, while pubs have risen by 47% due to an increase in their property valuations.. from BBC New...